Wednesday, June 10, 2026

pharma Β· Myotonic Dystrophy Type 1 Β· Myotonic Dystrophy Type 1 (DM1) Β· DYN

Dyne Therapeutics

Dyne Therapeutics trial registry β€” 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Waltham, USA HQ
2018 Founded
276 Employees
Public company Type
DYN Β· NYSE Ticker
Company details
Status
Public
HQ
Waltham, USA
Founded
2018
Employees
276
Programs
6
Drugs
11
Patents
82
Intelligence Β· Clinical Trials

Dyne Therapeutics clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Dyne Therapeutics programs β€” each row shows trial ID, program name, phase, status, and indication.

Dyne Therapeutics trial registry β€” 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Dyne Therapeutics.

  1. DYNE-101 for Myotonic Dystrophy Type 1 β€” Phase 2

    Clinical update
  2. DYNE251-DMD-201 β€” Phase 2

    Clinical update
  3. SODIUM CHLORIDE , DYNE-101 β€” Phase 3

    Clinical update
  4. zeleciment basivarsen (DYNE-101) β€” Phase 3

    Clinical update
  5. DYNE-251 β€” Phase 2

    Clinical update
  6. DYNE-101 β€” Phase 2

    Clinical update

Trial registry

6 studies